Volume 4, Issue 3 (9-2014)                   Iran J Ped Hematol Oncol 2014, 4(3): 103-108 | Back to browse issues page

XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Amoozgar H, Zareifar S, Borzoie M, Qasem F. Heart repolarization changes after anthracycline therapy in the children with cancer. Iran J Ped Hematol Oncol 2014; 4 (3) :103-108
URL: http://ijpho.ssu.ac.ir/article-1-172-en.html
Abstract:   (3213 Views)
Background Anthracyclines are important components of many chemotherapeutic protocols. The present study aimed to evaluate the repolarization changes in electrocardiography (ECG) which may predict drug induced arrhythmia. Materials and Methods In this cross-sectional study, the recorded ECGs were assessed for QT dispersion (QTd), QT corrected dispersion (QTcd), T peak to Tend dispersion (TPed), and P dispersion (Pd) in 12 ECG leads. The demographic information, including sex, age, and duration of drug consumption, were recorded, as well. Results In this study, 112 patients, including 58 females (52%) and 54 males (48%) with the mean age of 8.7±4.5 years, as the case group were compared with 43 children, including 17 males (40%) and 26 females (60%), in the control group. Most of our patients (88%) had received usual doses of anthracyclines i.e., 330 mg/m2. QT dispersion of the patients and the controls was 0.054±0.02 and 0.05± 0.02 seconds, respectively. No significant difference was found between the patients and the controls regarding corrected QT dispersion (P> 0.05). However, P dispersion time had increased in the patients' group. Our study showed that the duration of anthracyclines therapy did not cause any significant increase in ventricular re-polarization parameters. Conclusion Anthracyclines may show their cardiac toxicity through increasing P dispersion.
Full-Text [PDF 220 kb]   (1178 Downloads)    
Type of Study: Research | Subject: Heart
Received: 2014/09/11 | Accepted: 2014/09/11 | Published: 2014/09/11

Add your comments about this article : Your username or Email:
CAPTCHA

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Iranian Journal of Pediatric Hematology and Oncology

Designed & Developed by : Yektaweb